Tonix Pharmaceuticals was the most active symbol on Stocktwits before the bell on Wednesday as shares of the clinical-stage ...
A New Jersey-based biotech company is finding quite a bit of success so far during Tuesday’s premarket hours after the ...
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...
U.S. industrial production declined by 0.1% from the previous month in November compared to a 0.4% drop in October, and versus market estimates of a 0.2% gain. Commodities In commodity news, oil ...
FDA accepts Tonix’s NDA for TNX-102 SL, a non-opioid fibromyalgia treatment. Learn how this potential new drug addresses ...